This is so vastly different than adult onc/nephro isnt it? What makes the discrepancy so huge?
Most kids who get cancer or ESRD end up on Medicaid. Which does not even cover the cost of the high priced cancer drugs.
So the net income to the academic institution is a small amount or a loss.
Makes sense, from a payer mix standpoint. Would be interested to see the actual p/l of these centers specifically though.
Comment